Boris Bastian, MD, PhD

[DNA copy number changes in the diagnosis of melanocytic tumors].

Bauer J, Bastian BC PMID: 17882420

The prevalence and prognostic value of BRAF mutation in thyroid cancer.

Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A PMID: 17717450

Absence of PDGFRA mutations in primary melanoma.

Curtin JA, Pinkel D, Bastian BC PMID: 17762857

Expanding the genetic spectrum of pigmentation.

Bastian BC, Pinkel D PMID: 18721233

Lack of somatic alterations of MC1R in primary melanoma.

Kim RD, Curtin JA, Bastian BC PMID: 18761657

Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas.

Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T PMID: 17488338

Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach.

Thorns C, Bastian B, Pinkel D, Roydasgupta R, Fridlyand J, Merz H, Krokowski M, Bernd HW, Feller AC PMID: 17044049

In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.

Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin JA, Bastian BC, Springer C, Marais R PMID: 17018604

Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.

Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian BC, Soengas MS PMID: 16964246

Somatic activation of KIT in distinct subtypes of melanoma.

Curtin JA, Busam K, Pinkel D, Bastian BC PMID: 16908931